LEP and obesity due to melanocortin 4 receptor deficiency: Meanwhile, data began accumulating on the pathophysiological changes in leptin production and signaling that take place in obese subjects (13), eventually leading to realization of the unfeasibility and lack of strong biological basis for using leptin as a therapeutic approach to obesity.